Drug companies overcharge in ways that are unique to their industry. America's patent system should reward innovation, not lawyering: Our view        

Topics:  drug   
BING NEWS:
  • FTC looking to accelerate inquiry into prescription-drug middlemen, Khan says
    The Federal Trade Commission is looking to speed up its inquiry into prescription-drug middlemen while also expanding its scrutiny of drug patents, FTC ...
    04/23/2024 - 6:06 am | View Link
  • More